You think.
"Providing a complete abscopal response as seen in case study 1, potentially represents a new frontier in cancer therapy.
"http://www.noxopharm.com/irm/PDF/1520_1/EvidenceofAbscopalResponsesinPatients
Seems to be a lot of potential riding on case one. http://www.noxopharm.com/irm/PDF/1522_1/TROGAnnualScientificMeetingNoxopharmPresentation21318
The Abscopal Response Updated and Reviewed, page-10
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $29.22M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 9.9¢ | $4.773K | 48.10K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20574 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 38542 | 2 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| NOX (ASX) Chart |
